A U.K. pharmaceutical industry trade group suspended Novo Nordisk for two years ...
Giving an old genome-editing tool a new twist, Seamless Therapeutics launches ba...
‘We’ll look back and say that this was a bargain.’ Takeda reveals first data fro...